Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi Prime Europe UCITS ETF Acc

PRAE · LU2089238039 · class UCITS ETF Acc · EUR · domicile Luxembourg
Equity · Europe · Mid capSFDR art. 6
Index tracked: Solactive GBS Developed Markets Europe Large & Mid Cap EUR Index NTR
TER
0.05%+ trans. 0.16%
Fund size
260 m EUR
Tracking difference
+0.34%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 15 Jan 2020 · costs from the KID as of 2 Sept 2026 · 399 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of Solactive GBS Developed Markets Europe Large & Mid Cap EUR Index, and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Net Total Return Index : dividends net of tax paid by the index constituents are included in the Index return. Solactive GBS Developed Markets…

Performance since series start (in euro) — base 100

21 Jan 20208 Sept 2026 · dividends reinvested where declared by the issuer
20212022202320242025202618866185
High 188 (11 Aug 2026) · low 66 (23 Mar 2020) · last 185. Past performance is not indicative of future results.

Returns in euro

1 year+22.4%
3 years+56.0%
5 years+61.1%
10 yearsseries too young
Since series start+85.1%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.20%12.32%13.86%
Max drawdown−9.37%−16.49%−19.66%
Sharpe1.480.990.58
Sortino2.291.390.81
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · PRAE · LU20892380391
RebalixPRAE · LU2089238039 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+19.81%+19.55%+0.26%
2024+9.14%+8.69%+0.45%
2023+16.23%+15.92%+0.31%
2022−9.55%−9.88%+0.34%
2021+25.77%+25.46%+0.31%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 399 securities · top-10 weight = 21.3%
Top holdingsWeight
ASML HOLDING NV4.5%
HSBC HOLDINGS PLC2.5%
ROCHE HOLDING AG - GENUSSS CHF2.1%
NOVARTIS AG-REG2.1%
SHELL PLC GBP1.8%
NESTLE SA-REG1.8%
ASTRAZENECA GBP1.7%
SIEMENS AG-REG1.7%
SAP SE / XETRA1.6%
BANCO SANTANDER SA MADRID1.5%
Countries (% of fund)
United Kingdom22.9%France13.9%Germany13.6%Switzerland13.5%Netherlands8.4%
Sectors (% of fund)
Financials26.3%Industrials18.2%Health Care13.1%Information Technology8.8%Consumer Staples8.3%

Listing venues

ESMA register (FIRDS) and official exchange lists
PRAE · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 15 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/LU2089238039/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/LU2089238039/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/LU2089238039/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/LU2089238039
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · PRAE · LU20892380392